Charlotte Primard

1.3k total citations · 1 hit paper
22 papers, 964 citations indexed

About

Charlotte Primard is a scholar working on Pharmaceutical Science, Immunology and Molecular Biology. According to data from OpenAlex, Charlotte Primard has authored 22 papers receiving a total of 964 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmaceutical Science, 7 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Charlotte Primard's work include Immunotherapy and Immune Responses (7 papers), Advanced Drug Delivery Systems (7 papers) and HIV Research and Treatment (6 papers). Charlotte Primard is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Advanced Drug Delivery Systems (7 papers) and HIV Research and Treatment (6 papers). Charlotte Primard collaborates with scholars based in France, Spain and United Kingdom. Charlotte Primard's co-authors include Bernard Verrier, Thierry Delair, Federica Roccio, Tassula Proikas‐Cezanne, Fulvio Reggiori, Catherine J. Hunter, Nicolas Dupont, Stéphane Paul, Nicolas Rochereau and Christian Genin and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and Frontiers in Immunology.

In The Last Decade

Charlotte Primard

22 papers receiving 959 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The ménage à trois of autophagy, lipid droplets and liver disease

2021 228 citations Catherine J. Hunter, Federica Roccio et al. Autophagy profile →

Peers

Countries citing papers authored by Charlotte Primard

Since Specialization

Citations

This map shows the geographic impact of Charlotte Primard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Primard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Primard more than expected).

Fields of papers citing papers by Charlotte Primard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte Primard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Primard. The network helps show where Charlotte Primard may publish in the future.

Co-authorship network of co-authors of Charlotte Primard

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte Primard. A scholar is included among the top collaborators of Charlotte Primard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte Primard. Charlotte Primard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	OVX033, a nucleocapsid-based vaccine candidate, provides broad-spectrum protection against SARS-CoV-2 variants in a hamster challenge model 2023 ·Frontiers in Immunology ·Charlotte Primard, Élodie Monchâtre-Leroy, Judith del Campo, (unknown), (unknown), (unknown), Franck Boué, Alexandre Servat, Marine Wasniewski, Evelyne Picard‐Meyer, Thomas Courant, Nicolas Collin, Francisco J. Salguero, (unknown), (unknown), (unknown)	16
2	Design and Evaluation of Autophagy-Inducing Particles for the Treatment of Abnormal Lipid Accumulation 2022 ·Pharmaceutics ·(unknown), (unknown), (unknown), (unknown), Eeva‐Liisa Eskelinen, Ganna Panasyuk, Bernard Verrier, Charlotte Primard	9
3	The ménage à trois of autophagy, lipid droplets and liver disease breakdown → 2021 ·Autophagy ·(unknown), Catherine J. Hunter, Federica Roccio, (unknown), Nicolas Dupont, Charlotte Primard, Tassula Proikas‐Cezanne, Fulvio Reggiori	228
4	Biodistribution of surfactant-free poly(lactic-acid) nanoparticles and uptake by endothelial cells and phagocytes in zebrafish: Evidence for endothelium to macrophage transfer. 2021 ·Journal of Controlled Release ·Julien Rességuier, Jean‐Pierre Levraud, (unknown), Federico Fenaroli, Charlotte Primard, Jens Wohlmann, (unknown), Gareth Griffiths, Dominique Le Guellec, Bernard Verrier	9
5	Surface charge modulation of rifampicin-loaded PLA nanoparticles to improve antibiotic delivery in Staphylococcus aureus biofilms 2021 ·Journal of Nanobiotechnology ·David Da Costa, (unknown), (unknown), Simon Mégy, Raphaël Terreux, Bernard Verrier, Charlotte Primard	58
6	Development of an antibacterial nanocomposite hydrogel for human dental pulp engineering 2020 ·Journal of Materials Chemistry B ·Mourad Bekhouche, (unknown), (unknown), (unknown), David Da Costa, Charlotte Primard, A. Costantini, Marielle Pasdeloup, Stéphanie Gobert, Frédéric Mallein‐Gérin, Bernard Verrier, Maxime Ducret, Jean‐Christophe Farges	40
7	Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 2019 ·Frontiers in Immunology ·(unknown), (unknown), Charanjit Singh, Ekaterina Kinnear, David C. Busse, Annalisa Ciabattini, Fabio Fiorino, Donata Medaglini, Claudia Maria Trombetta, Emanuele Montomoli, Vanessa Contreras, Roger Le Grand, (unknown), Charlotte Primard, Bernard Verrier, John S. Tregoning	3
8	Driving next-generation autophagy researchers towards translation (DRIVE), an international PhD training program on autophagy 2018 ·Autophagy ·Claudine Kraft, Patricia Boya, Patrice Codogno, Zvulun Elazar, Eeva‐Liisa Eskelinen, Judith Farrés, Vladimir Kirkin, Heinz Jungbluth, Ana Martı́nez, Ole Pleß, Charlotte Primard, Tassula Proikas‐Cezanne, Anne Simonsen, Fulvio Reggiori	4
9	Antibiotic incorporation in jet-sprayed nanofibrillar biodegradable scaffolds for wound healing 2017 ·International Journal of Pharmaceutics ·(unknown), (unknown), (unknown), Bernard Verrier, Charlotte Primard, Jérôme Sohier	13
10	Critical Role for Skin-Derived Migratory DCs and Langerhans Cells in TFH and GC Responses after Intradermal Immunization 2017 ·Journal of Investigative Dermatology ·(unknown), Olivia Bonduelle, (unknown), Charlotte Primard, Bernard Verrier, Alexandre Boissonnas, Béhazine Combadière	53
11	Innovative drug vehicle for local treatment of inflammatory skin diseases: Ex vivo and in vivo screening of five topical formulations containing poly(lactic acid) (PLA) nanoparticles 2016 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), (unknown), (unknown), (unknown), Plamen Kirilov, Charlotte Primard, Fabrice Pirot, Bérengère Fromy, Bernard Verrier	29
12	Zinc-Stabilized Chitosan-Chondroitin Sulfate Nanocomplexes for HIV-1 Infection Inhibition Application 2016 ·Molecular Pharmaceutics ·Danjun Wu, (unknown), Bernard Verrier, Charlotte Primard, Armelle Cuvillier, (unknown), Stéphane Paul, Thierry Delair	32
13	Zinc-stabilized colloidal polyelectrolyte complexes of chitosan/hyaluronan: a tool for the inhibition of HIV-1 infection 2016 ·Journal of Materials Chemistry B ·Danjun Wu, (unknown), Bernard Verrier, Charlotte Primard, Armelle Cuvillier, (unknown), Stéphane Paul, Thierry Delair	19
14	Co-delivery of Antigen p24 and NOD-ligands by PLA Nanoparticles to Human Dendritic Cells Promote Highly Functional HIV-1-Specific T-cell Responses 2014 ·AIDS Research and Human Retroviruses ·Núria Climent, Vincent Pavot, Felipe García, Thierry Lioux, Éric Pérouzel, Charlotte Primard, Stéphane Paul, José María Gatell, Montserrat Plana, Bernard Verrier, Teresa Gallart	1
15	Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses 2014 ·Vaccine ·Núria Climent, Séverine Munier, Núria Piqué, Felipe García, Vincent Pavot, Charlotte Primard, Víctor Casanova, José María Gatell, Bernard Verrier, Teresa Gallart	18
16	Encapsulation of Nod1 and Nod2 receptor ligands into poly(lactic acid) nanoparticles potentiates their immune properties 2013 ·Journal of Controlled Release ·Vincent Pavot, Nicolas Rochereau, Charlotte Primard, Christian Genin, Éric Pérouzel, Thierry Lioux, Stéphane Paul, Bernard Verrier	74
17	Multifunctional PLGA-Based Nanoparticles Encapsulating Simultaneously Hydrophilic Antigen and Hydrophobic Immunomodulator for Mucosal Immunization 2013 ·Molecular Pharmaceutics ·Charlotte Primard, (unknown), (unknown), Emmanuelle Sublet, Farnaz Esmaeili, Gerrit Borchard	42
18	Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells 2010 ·Biomaterials ·Charlotte Primard, Nicolas Rochereau, (unknown), Christian Genin, Thierry Delair, Stéphane Paul, Bernard Verrier	86
19	Investigation of Polylactic Acid (PLA) Nanoparticles as Drug Delivery Systems for Local Dermatotherapy 2009 ·Pharmaceutical Research ·Fiorenza Rancan, Dimitrios Papakostas, Sabrina Hadam, Steffen Hackbarth, Thierry Delair, Charlotte Primard, Bernard Verrier, Wolfram Sterry, Ulrike Blume‐Peytavi, Annika Vogt	183
20	Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbits 2007 ·Vaccine ·Christophe Guillon, Katia Mayol, (unknown), Christelle Compagnon, Charlotte Primard, (unknown), Thierry Delair, Séverine Munier, Bernard Verrier	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact